Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Treating depression early could save cancer patients' lives. A large study of over 265,000 older adults found that cancer patients with major depressive disorder who received psychotherapy within 4 weeks of diagnosis had a 21% lower risk of cancer-specific death — yet fewer than 5% actually got it that early. The findings make a strong case for integrating mental health screening into routine cancer care from day one.
A new study presented at the ASTRO 2026 Annual Meeting found that cancer patients with major depressive disorder (MDD) who received psychotherapy within 4 weeks of their diagnosis had a 21% lower risk of dying from their cancer compared to those who didn't receive psychotherapy. The analysis drew on SEER-Medicare data covering over 265,000 adults aged 66+ diagnosed with breast, prostate, colorectal, bladder, kidney, or non-small cell lung cancer between 2010 and 2017.
The catch? Only 3% of patients with depression actually received psychotherapy within 4 weeks of diagnosis — even though roughly 1 in 5 patients in the cohort had MDD. The benefit also faded with time: psychotherapy at 8 weeks was linked to a 13% risk reduction, and at 12 weeks, just 12%. Antidepressants, while more commonly prescribed (32.5% within 4 weeks), showed no significant mortality benefit across the overall cohort.
Why it matters: Depression is common in cancer patients yet chronically undertreated. This study suggests that early psychotherapy — not just medication — could meaningfully improve survival outcomes, pointing to a critical and actionable gap in comprehensive cancer care.
